These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24504817)

  • 21. Vasculitis in the geriatric population.
    Langford CA
    Clin Geriatr Med; 2005 Aug; 21(3):631-47, viii. PubMed ID: 15911211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.
    Saadoun D; Pineton de Chambrun M; Hermine O; Karras A; Choquet S; Jego P; Decaux O; Cacoub P
    Arthritis Care Res (Hoboken); 2013 Apr; 65(4):643-7. PubMed ID: 22972527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis combined with corticosteroids and cyclophosphamide in mixed monoclonal cryoglobulinaemia.
    Verdickt W; Dequeker J
    Acta Clin Belg; 1982; 37(4):237-40. PubMed ID: 7148324
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cryoglobulinemic vasculitis].
    Gause A; Lamprecht P
    Internist (Berl); 2003 Feb; 44(2):165-6, 169-74. PubMed ID: 12674736
    [No Abstract]   [Full Text] [Related]  

  • 25. Relapsing polychondritis associated with mixed cryoglobulinemia.
    Sidi Y; Weinberger A; Berliner S; Ben-Bassat M; Idesses C; Feuerman EJ; Pinkhas J
    Dermatologica; 1982 Jul; 165(1):66-70. PubMed ID: 7117651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II.
    Moberg P; Charles JF; Respicio G; Venna SS; Rooney T
    Cutis; 2010 Sep; 86(3):133-5. PubMed ID: 21049729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Treatment With Bosentan for Digital Ulcers Related to Mixed Cryoglobulinemia: A Case Report.
    de Lorenzo-Pinto A; Pinilla Llorente B
    Am J Ther; 2016; 23(6):e1942-e1943. PubMed ID: 26785421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab.
    Koukoulaki M; Abeygunasekara SC; Smith KG; Jayne DR
    Nephrol Dial Transplant; 2005 Jan; 20(1):213-6. PubMed ID: 15632353
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of vasculitis.
    Taylor HG; Samanta A
    Br J Clin Pharmacol; 1993 Feb; 35(2):93-104. PubMed ID: 8443041
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis C virus-associated cryoglobulinemic vasculitis. Physiopathology, diagnosis and therapy].
    Lamprecht P; Schnabel A; Gross WL
    Dtsch Med Wochenschr; 1998 May; 123(20):637-42. PubMed ID: 9627573
    [No Abstract]   [Full Text] [Related]  

  • 31. A primer on vasculitis.
    Warrington KJ; Matteson EL
    Minn Med; 2013 May; 96(5):36-9. PubMed ID: 23833834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia.
    Agarwal A; Clements J; Sedmak DD; Imler D; Nahman NS; Orsinelli DA; Hebert LA
    J Am Soc Nephrol; 1997 Dec; 8(12):1971-6. PubMed ID: 9402102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
    Guillevin L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
    [No Abstract]   [Full Text] [Related]  

  • 34. Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances.
    Ghetie D; Mehraban N; Sibley CH
    Rheum Dis Clin North Am; 2015; 41(1):93-108, viii-ix. PubMed ID: 25399942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryoglobulinemic vasculitis in pregnancy.
    Gupta A; Gupta G; Marouf R
    Int J Gynaecol Obstet; 2008 Nov; 103(2):177-8. PubMed ID: 18687432
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic immunomodulation in systemic vasculitis: taking stock.
    Puéchal X; Guillevin L
    Joint Bone Spine; 2013 Jul; 80(4):374-9. PubMed ID: 23237994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
    Cohen C; Mekinian A; Saidenberg-Kermanac'h N; Stirnemann J; Fenaux P; Gherardi R; Fain O
    Ann Rheum Dis; 2012 Apr; 71(4):628-9. PubMed ID: 22121135
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
    St Clair EW
    Arthritis Rheum; 2012 Mar; 64(3):604-8. PubMed ID: 22147537
    [No Abstract]   [Full Text] [Related]  

  • 39. Mixed Cryoglobulin-induced Esophageal Necrosis in a Patient With Hepatitis C.
    Kimani M; Darling JM; Barritt AS
    J Clin Gastroenterol; 2016 Jul; 50(6):524. PubMed ID: 27035077
    [No Abstract]   [Full Text] [Related]  

  • 40. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.